Browse current and past press releases from The Michael J. Fox Foundation.
-
Michael J. Fox Foundation Commits up to $2 Million For PD Drug Development Under Target Validation 2008
-
Katie Hood Appointed Interim Chief Executive Officer of Michael J. Fox Foundation
-
Michael J. Fox Foundation and New York Academy of Sciences to Host First Major Parkinson's Drug Development Conference
-
MJFF Announces $1.2 Million in Funding to Advance Development of Drug Targets For PD
-
-
MJFF Awards $710,000 to Advance Understanding of Parkinson's Disease Subtypes
-
Michael J. Fox Foundation Commits up to $5 Million for 2007-2008 Therapeutics Development Initiative